Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all synonyms
Human Polyclonal REPS2 Primary Antibody for ICC, IF - ABIN4350005
Aguilera, González-Sancho, Zazo, Rincón, Fernández, Tapia, Canals, Morte, Calvanese, Orgaz, Niell, Aguilar, Freije, Graña, Pisano, Borrero, Martínez-Useros, Jiménez, Fraga, García-Foncillas et al.: Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer. ... in Oncotarget 2015
miR (show MLXIP Antibodies)-675-5p might play an oncogenic role in esophageal squamous cell carcinoma (ESCC) through RalBP1 (show RALBP1 Antibodies)/RAC1/CDC42 (show CDC42 Antibodies) signaling pathway by inhibiting REPS2 and might serve as a valuable prognostic biomarker and therapeutic target for ESCC patients.
downregulation of REPS2 may contribute to malignant progression of esophageal squamous cell carcinoma and represent a novel prognostic marker and a potential therapeutic target for esophageal squamous cell carcinoma patients.
These results suggest that POB1 interacts with PAG2 through its proline-rich motif, thereby regulating cell migration.
POB1 (show TRIM37 Antibodies), through its influence on the Ral (show rala Antibodies) signalling pathway, is involved in growth factor signalling and consequently in control of cell proliferation
decreased expression of REPS2 might be a key factor, causing prostate cancer cells to become resistant to induction of apoptosis by androgen deprivation.
Decreased REPS2 expression is associated with androgen-independent state of advanced prostate cancer
These results show for the first time that POB1 (show TRIM37 Antibodies) can regulate the transport function of RLIP76 (show RALBP1 Antibodies) and are consistent with our previous studies showing that inhibition of RLIP76 (show RALBP1 Antibodies) induces apoptosis in cancer cells.
Hsf-1 (show HSF1 Antibodies) causes specific and saturable inhibition of the transport activity of Ralbp1 (show RALBP1 Antibodies) and that the combination of Hsf-1 (show HSF1 Antibodies) and POB1 (show TRIM37 Antibodies) causes nearly complete inhibition through specific bindings with Ralbp1 (show RALBP1 Antibodies).
REPS2 may be a useful tumor marker for favorable prognosis in breast cancer.
The product of this gene is part of a protein complex that regulates the endocytosis of growth factor receptors. The encoded protein directly interacts with a GTPase activating protein that functions downstream of the small G protein Ral. Its expression can negatively affect receptor internalization and inhibit growth factor signaling. Multiple transcript variants encoding different isoforms have been found for this gene.
RALBP1-interacting protein 2
, partner of Ral-binding protein 1
, partner of RalBP1
, ralBP1-associated Eps domain-containing protein 2
, RALBP1-associated Eps domain containing protein 2
, ralBP1-interacting protein 2